A Trial of Doxil and Multiday Vinorelbine in Patients With Metastatic Breast Cancer

NCT00159094 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Metastatic Breast Cancer

Interventions

DRUG: Doxil and Vinorelbine

Sponsor

Hematology Oncology Consultants

Collaborators

[object Object]